XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) is a Epidural; Infiltration; Intracaudal; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Lidocaine Hydrochloride Anhydrous; Epinephrine Bitartrate.
| Product ID | 51662-1405_971439ed-4508-7a30-e053-2a95a90a1f1c |
| NDC | 51662-1405 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE) |
| Generic Name | Xylocaine(r) -mpf (lidocaine Hci And Epinephrine) |
| Dosage Form | Injection, Solution |
| Route of Administration | EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL |
| Marketing Start Date | 2019-11-11 |
| Marketing Category | NDA / NDA |
| Application Number | NDA006488 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | LIDOCAINE HYDROCHLORIDE ANHYDROUS; EPINEPHRINE BITARTRATE |
| Active Ingredient Strength | 10 mg/mL; mg/mL |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE],Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |